Valneva Completes Recruitment for Phase 3 Lot-to-Lot Consistency Trial of its Chikungunya …,

VLA1553 is the only chikungunya vaccine candidate in Phase 3 clinical trials at this time. 410 participants aged 18 to 45 years have been randomized …, VLA1553 is the only chikungunya vaccine candidate in Phase 3 clinical trials at this time. 410 participants aged 18 to 45 years have been randomized …, Read More

Scroll to Top